Asia Pacific Carboxy Therapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Tabletop, Portable, and Others), Application [Aesthetic Medicine (Cellulite, Stretch Marks, Alopecia, and Dark Under-Eye Circles), Dermatology, Gynecol

Asia Pacific Carboxy Therapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Tabletop, Portable, and Others), Application [Aesthetic Medicine (Cellulite, Stretch Marks, Alopecia, and Dark Under-Eye Circles), Dermatology, Gynecology, Angiology, Orthopedics & Rheumatology, Sports Medicine, and Others], and End User (Hospitals, Aesthetic Clinics, and Wellness Center)

The Asia Pacific carboxy therapy market is expected to grow from US$ 21.16 million in 2022 to US$ 43.49 million by 2028. It is estimated to grow at a CAGR of 12.8% from 2022 to 2028.

Increase in Application Areas of Carboxy Therapies will be driving the Asia Pacific Carboxy Therapy Market in Upcoming Years

The healthcare industry is constantly developing significantly due to the increasing prevalence of various disorders. Moreover, increasing awareness among people and changing beauty standards have fueled the demand for aesthetics and beauty treatments, boosting the need for various devices and treatments. When CO2 gas is injected into the body, it relaxes the blood vessels. It stimulates blood supply in that specific area by eliminating fat cells, which has shown impressive results in beauty and aesthetics. This has encouraged healthcare professionals to try carboxy therapy to treat various disorders in different areas, such as gynecology, neurology, urology, and sports medicine. For instance, carboxy therapy is widely used to treat vaginal insufficiency syndrome caused by reduced blood flow. Erectile dysfunction is also treated with the help of carboxy therapy nowadays. Moreover, carboxy therapy is one of the affordable treatment options which seems safe and effective, covering the broad therapeutic area, which is further expected to expand significantly in the near future. Moreover, the increase in application areas for carboxy therapy has created ample opportunities for carboxy therapy device manufacturers to develop and launch various devices, which further help deliver carboxy therapy. Thus, an increase in application areas of carboxy therapy, a surge in product launches, and further innovation in carboxy therapy devices are expected to promote the growth of the Asia Pacific carboxy therapy market during the forecast period.

Asia Pacific Carboxy Therapy Market Overview

The Asia Pacific carboxy therapy market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. The market is driven by factors such as large populations in countries such as China and India, increased focus of market players in this region, and the introduction of new products or therapies in the above countries. Minimally invasive facial cosmetic surgery (MIFCS) is becoming increasingly popular and acceptable among young Chinese people, and it influences people in various aspects. In China, more and more young consumers, especially females, are looking for noninvasive cosmetic options to improve their appearance with immediate and visible effects. Some of them would purchase such treatments regularly. As per a survey result released in May 2021, about 7% of the Chinese respondents who had taken nonsurgical beauty treatments said they did so once per month. Another 18.6% made the purchase once per quarter. According to the WHO, China has one of the fastest-growing aging populations in the world. In 2019, there were 254 million people aged 60 and over, and 176 million people aged 65 and over in China. In addition, the population of people over 60 years in China is projected to reach 28% by 2040 due to longer life expectancy and declining fertility rates. Thus, the increasing geriatric population, which opts for carboxy therapy for cosmetic procedures, is expected to drive the market during the forecast period.

Asia Pacific Carboxy Therapy Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Carboxy Therapy Market Segmentation

The Asia Pacific carboxy therapy market is segmented into type, application, end user, and country.

Based on type, the Asia Pacific carboxy therapy market is segmented into tabletop, portable, and others. The tabletop segment is expected to hold the largest market share by 2022.

Based on application, the Asia Pacific carboxy therapy market is segmented into aesthetic medicine, dermatology, angiology, gynecology, orthopedics and rheumatology, sports medicine, and others. The aesthetic medicine segment is expected to hold the largest market share by 2022. The aesthetic medicine segment is further subsegmented into cellulite, stretch marks, alopecia, and dark under-eye circles.

Based on end user, the Asia Pacific carboxy therapy market is segmented into hospitals, aesthetic clinics, and wellness centers. The hospitals segment is expected to hold the largest market share by 2022.

Based on country, the Asia Pacific carboxy therapy market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. China dominated the market share in 2022.

Carbossiterapia Italiana; DTA Medical; Kastner-Praxisbedarf; MBE Medical Division; and Mezopharma are among the leading companies operating in the carboxy therapy market in Asia Pacific.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific carboxy therapy market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific carboxy therapy market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the carboxy therapy market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution